Veena Shankaran
Publications by Year
Research Areas
Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life, Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade(2017)3,762 cited
- → Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial(2016)1,123 cited
- → Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer(2016)878 cited
- → Risk Factors for Financial Hardship in Patients Receiving Adjuvant Chemotherapy for Colon Cancer: A Population-Based Exploratory Analysis(2012)285 cited
- → Navigating financial toxicity in patients with cancer: A multidisciplinary management approach(2022)239 cited
- → Pilot Feasibility Study of an Oncology Financial Navigation Program(2017)199 cited
- → An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer(2017)131 cited
- → Relationship between PD-L1 expression and clinical outcomes in patients (Pts) with advanced gastric cancer treated with the anti-PD-1 monoclonal antibody pembrolizumab (Pembro; MK-3475) in KEYNOTE-012.(2015)118 cited
- Impact of trained oncology financial navigators on patient out-of-pocket spending.(2018)
- → Financial Toxicity in Cancer Care: Implications for Clinical Care and Potential Practice Solutions(2023)96 cited